{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:53:05Z","timestamp":1791103985020,"version":"4.1.0"},"reference-count":59,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3683,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1111\/j.0022-202x.2005.23808.x","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T19:59:31Z","timestamp":1484337571000},"page":"353-363","source":"Crossref","is-referenced-by-count":18,"title":["Expression of gp130 in Tumors and Inflammatory Disorders of the Skin: Formal Proof of its Identity as CD146 (MUC18, Mel-CAM)"],"prefix":"10.1111","volume":"125","author":[{"given":"Margarete","family":"Sch\u00f6n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"K\u00e4hne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Gollnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0010","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.4049\/jimmunol.131.3.1595","article-title":"Biochemical analysis of a 130,000 molecular weight glycoprotein on human melanoma cells","volume":"131","author":"Albino","year":"1983","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/bbrc.1996.0037","article-title":"Identification of the S-Endo 1 endothelial-associated antigen","volume":"218","author":"Bardin","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1399-0039.1996.tb02666.x","article-title":"S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen","volume":"48","author":"Bardin","year":"1996","journal-title":"Tissue Antigens"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0025","first-page":"2902","article-title":"Cell-mediated cytotoxicity for bladder carcinoma: Evaluation of a workshop","volume":"35","author":"Bean","year":"1975","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.106.3.761","article-title":"Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line","volume":"106","author":"Boukamp","year":"1988","journal-title":"J Cell Biol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0035","first-page":"121","article-title":"Expression of surface antigens and its relation to parameters of malignancy in human malignant melanoma","volume":"10","author":"Bruggen","year":"1981","journal-title":"Cancer Immunol Immunother"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0040","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1514::AID-CNCR12>3.0.CO;2-Q","article-title":"Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer","volume":"85","author":"Delehedde","year":"1999","journal-title":"Cancer"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0045","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1073\/pnas.77.10.6114","article-title":"Cell surface antigens of human malignant melanoma: Definition of six antigenic systems with mouse monoclonal antibodies","volume":"77","author":"Dippold","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0050","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jnci\/51.5.1417","article-title":"In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors","volume":"51","author":"Giard","year":"1973","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0065-230X(03)90005-4","article-title":"Immunity to cancer through immune recognition of altered self: Studies with malignant melanoma","volume":"90","author":"Guevara-Patino","year":"2003","journal-title":"Adv Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000097321","article-title":"Detection of the novel cell adhesion molecule MUC18 in human brain tissue","volume":"4","author":"Hampel","year":"1997","journal-title":"Neuroimmunomodulation"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0065","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ijc.2910410412","article-title":"Glycoprotein P3.58, associated with tumor progression in malignant melanoma, is a novel leukocyte activation antigen","volume":"41","author":"Holzmann","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0070","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.156.6.1755","article-title":"Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets","volume":"156","author":"Houghton","year":"1982","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0075","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<769::AID-IJC26>3.0.CO;2-#","article-title":"Melanoma progression-associated glycoprotein MUC18\/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand","volume":"73","author":"Johnson","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0080","first-page":"338","article-title":"Functional aspects of three molecules associated with metastasis development in human malignant melanoma","volume":"9","author":"Johnson","year":"1989","journal-title":"Invasion Metastasis"},{"issue":"Pt 1","key":"10.1111\/j.0022-202X.2005.23808.x_bb0085","first-page":"95","article-title":"MUC18: A cell adhesion molecule with a potential role in tumor growth and tumor cell dissemination","volume":"213","author":"Johnson","year":"1996","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0090","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1084\/jem.167.5.1684","article-title":"A transformation-associated 130-kD cell surface glycoprotein is growth controlled in normal human cells","volume":"167","author":"Klein","year":"1988","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0095","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1365-4362.2003.01821.x","article-title":"Examination of Bcl-2, Bcl-X and bax protein expression in psoriasis","volume":"42","author":"Kocak","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0100","first-page":"4377","article-title":"Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens","volume":"23","author":"Kuroki","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0105","first-page":"4255","article-title":"Significance of tumor-associated antigens in the diagnosis and therapy of cancer: An overview","volume":"22","author":"Kuroki","year":"2002","journal-title":"Anticancer Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0110","first-page":"841","article-title":"Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000","volume":"47","author":"Lehmann","year":"1987","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0115","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1073\/pnas.86.24.9891","article-title":"MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily","volume":"86","author":"Lehmann","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0120","first-page":"6560","article-title":"A fully human antimelanoma cellular adhesion molecule\/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo","volume":"9","author":"McGary","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0125","first-page":"5106","article-title":"Fully human antibodies to MCAM\/MUC18 inhibit tumor growth and metastasis of human melanoma","volume":"62","author":"Mills","year":"2002","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0130","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archderm.1995.01690200045009","article-title":"Bcl-2 expression in primary malignancies of the skin","volume":"131","author":"Morales-Ducret","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s004030000158","article-title":"Bcl-2 transfected HaCaT keratinocytes resist apoptotic signals of ceramides, tumor necrosis factor alpha, and 1-alpha, 25-dihydroxyvitamin D(3)","volume":"292","author":"M\u00fcller-Wieprecht","year":"2000","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/excr.2001.5173","article-title":"The melanoma antigen genes\u2014any clues to their functions in normal tissues?","volume":"265","author":"\u00d6hman Forslund","year":"2001","journal-title":"Exp Cell Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0145","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.4049\/jimmunol.158.5.2107","article-title":"MUC18\/MCAM (CD146), an activation antigen of human T lymphocyte","volume":"158","author":"Pickl","year":"1997","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1600-0560.2000.027006283.x","article-title":"Bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas","volume":"27","author":"Ramdial","year":"2000","journal-title":"J Cutan Pathol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0155","first-page":"4401","article-title":"Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: Specificity analysis and comparison of antigen expression in cultured cells and tissues","volume":"45","author":"Real","year":"1985","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0160","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1586\/14737140.4.4.569","article-title":"Combination epidermal growth factor receptor inhibition and radical radiotherapy for NSCLC","volume":"4","author":"Rogers","year":"2004","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0165","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1074\/mcp.R400001-MCP200","article-title":"Targeted therapy in breast cancer: The HER-2\/neu gene and protein","volume":"3","author":"Ross","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0170","first-page":"333","article-title":"Targeted therapy for cancer: The HER-2\/neu and Herceptin story","volume":"17","author":"Ross","year":"2003","journal-title":"Clin Leadersh Manag Rev"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0175","first-page":"2218","article-title":"Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC18\/MCAM","volume":"56","author":"Rummel","year":"1996","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0180","first-page":"657","article-title":"Technology evaluation: Bevacizumab, Genentech\/Roche","volume":"5","author":"Salgaller","year":"2003","journal-title":"Curr Opin Mol Ther"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0749-2081(03)00045-7","article-title":"Trends in cancer therapy: Role of monoclonal antibodies","volume":"19","author":"Schmidt","year":"2003","journal-title":"Semin Oncol Nurs"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0190","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/djg016","article-title":"Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod","volume":"95","author":"Sch\u00f6n","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0195","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1523-1747.2000.00189.x","article-title":"Basal-cell adhesion molecule (B-CAM) is induced in epithelial skin tumors and inflammatory epidermis, and is expressed at cell\u2013cell and cell\u2013substrate contact sites","volume":"115","author":"Sch\u00f6n","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0200","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/1523-1747.ep12321113","article-title":"Characterization of an 80-kD membrane glycoprotein (gp80) of human keratinocytes: A marker for commitment to terminal differentiation in vivo and in vitro","volume":"105","author":"Sch\u00f6n","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0205","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ijc.2910600113","article-title":"Transformation of human keratinocytes is characterized by quantitative and qualitative alterations of the T-16 antigen (Trop-2, MOv-16)","volume":"60","author":"Sch\u00f6n","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0210","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/ijc.2910550619","article-title":"Biochemical and immunological characterization of the human carcinoma-associated antigen MH99\/KS1\/4","volume":"55","author":"Sch\u00f6n","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0215","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.0022-202X.2004.22528.x","article-title":"Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod","volume":"122","author":"Sch\u00f6n","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0220","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000026347","article-title":"Melanoma-associated adhesion molecule MUC18\/MCAM (CD146) and transcriptional regulator mader in normal human CNS","volume":"5","author":"Schwarz","year":"1998","journal-title":"Neuroimmunomodulation"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0225","doi-asserted-by":"crossref","first-page":"8514","DOI":"10.1073\/pnas.90.18.8514","article-title":"Genomic organization of the melanoma-associated glycoprotein MUC18: Implications for the evolution of the immunoglobulin domains","volume":"90","author":"Sers","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0230","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/ac950914h","article-title":"Mass spectrometric sequencing of proteins from silver stained polyacrylamide gels","volume":"68","author":"Shevchenko","year":"1996","journal-title":"Anal Chem"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0235","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P","article-title":"The role of CD146 (Mel-CAM) in biology and pathology","volume":"189","author":"Shih","year":"1999","journal-title":"J Pathol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0240","first-page":"837","article-title":"Regulation of Mel-CAM\/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes","volume":"145","author":"Shih","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0245","first-page":"2514","article-title":"Isolation and functional characterization of the A32 melanoma-associated antigen","volume":"54","author":"Shih","year":"1994","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0250","first-page":"1098","article-title":"A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue","volume":"11","author":"Shih","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0255","first-page":"3835","article-title":"Melanoma cell\u2013cell interactions are mediated through heterophilic Mel-CAM\/ligand adhesion","volume":"57","author":"Shih","year":"1997","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0260","first-page":"3757","article-title":"Interaction between bcl-2 and P53 in neoplastic progression of basal cell carcinoma of the head and neck","volume":"21","author":"Staibano","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0265","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1159\/000030042","article-title":"Biological role of SCC antigen","volume":"19","author":"Suminami","year":"1998","journal-title":"Tumour Biol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0270","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1124\/jpet.104.070938","article-title":"Relationship between antiapoptotic molecules and metastatic potency and the involvement of DNA-dependent protein kinase in the chemosensitization of metastatic human cancer cells by epidermal growth factor receptor blockade","volume":"311","author":"Um","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0275","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1523-1747.2000.00039.x","article-title":"Keratinocytes express the CD146 (Muc18\/S-endo) antigen in tissue culture and during inflammatory skin diseases","volume":"115","author":"Weninger","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0280","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archderm.1997.03890410055007","article-title":"Bcl-2 vs p 53 protein expression and apoptotic rate in human nonmelanoma skin cancers","volume":"133","author":"Wikonkal","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0285","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nm988","article-title":"Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer","volume":"10","author":"Willett","year":"2004","journal-title":"Nat Med"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0290","first-page":"2295","article-title":"Expression of MCAM\/MUC18 by human melanoma cells leads to increased tumor growth and metastasis","volume":"57","author":"Xie","year":"1997","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0295","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/sj.onc.1201358","article-title":"Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells","volume":"15","author":"Xie","year":"1997","journal-title":"Oncogene"},{"key":"10.1111\/j.0022-202X.2005.23808.x_bb0300","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cdp.2003.12.006","article-title":"Tumor-associated antigen arrays to enhance antibody detection for cancer diagnosis","volume":"28","author":"Zhang","year":"2004","journal-title":"Cancer Detect Prevent"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15323903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15323903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0022-202X.2005.23808.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T19:00:19Z","timestamp":1692644419000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0022-202X.2005.23808.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0022202X15323903"],"URL":"https:\/\/doi.org\/10.1111\/j.0022-202x.2005.23808.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}